Animal Drugs Market Enterprise Overview, Analysis Insights,

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

The Business Research Company

New year, new updates! Our reports have been revised regarding market size, forecasts and strategies for 2021 after the effects of COVID-19:

The global veterinary market is projected to grow from $ 32.7 billion in 2020 to $ 37.88 billion in 2021, with an average annual growth rate (CAGR) of 15.8%. The growth is mainly due to companies reorganizing their operations and recovering from the effects of COVID-19, which had previously resulted in restrictive containment measures that included social distancing, remote working and the cessation of commercial activities that created operational challenges . The market is projected to reach $ 48.55 billion in 2025 with a 6% annual growth rate.

The Business Research Company offers “Animal Medicine Global Market Report 2021” in its Research Report Store. It is the most comprehensive report available on this market and will help to get a truly global perspective as it covers 60 regions. The “Breakdown by Region and Country” section has an analysis of the market in each region and the size of the market by region and country. It also compares the historical and projected growth of the market and highlights key trends and strategies that market participants can apply.


The veterinary market consists of the sale of veterinary medicines and related services by companies (organizations, sole proprietorships, and partnerships) that manufacture veterinary medicines to treat animal diseases and / or to improve animal performance and health. The veterinary industry includes facilities that manufacture veterinary drugs such as veterinary vaccines, veterinary antibiotics, and other veterinary drugs, as well as facilities that manufacture medical feed additives and feed additives.

Some of the key players in the veterinary market are Zoetis Inc., Boehringer Ingelheim GmbH, Bayer AG, Elanco Animal Health (Eli Lilly and Company), and Ceva Santé Animale.

The countries covered in the global veterinary medicine market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel , Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, UK, USA, Venezuela, Vietnam.

The regions covered by the global Animal Health Market are Asia Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Market segmentation veterinary medicine:
1) By type: veterinary drugs, feed additives
2) By species: livestock, domestic animals
3) According to intended use: veterinary clinics, pharmacies and drug stores, veterinary clinics

Search full report @

A couple of points from the table of contents
1. Summary
2. Report structure
3. Veterinary medicine market characteristics
4. Product analysis of the veterinary medicine market
5. Veterinary supply chain
21. Animal Medicine Market Competitive Landscape
22. Major mergers and acquisitions in the veterinary market
23. Market background: Veterinary medicine market
24. Recommendations
25. Appendix
26. Copyright and Disclaimer

The report covers the trends and market dynamics of the Veterinary Medicine market in key countries – Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future market opportunities.

Request a sample copy of this report @

Contact information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
America: +1 315 623 0293

About us:
The Business Research Company has published over 1000 industry reports covering over 2500 market segments and 60 regions. The reports draw on 150,000 data sets, extensive secondary research and exclusive insights from interviews with industry leaders. The reports will be updated with a detailed analysis of the impact of COVID-19 on different markets after the WHO declared COVID-19 a pandemic.

This version was published on openPR.